PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹309 Cr | ₹330 Cr | ₹774 Cr | ₹447 Cr | ₹622 Cr |
What is the latest Total Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹309 Cr |
Mar2023 | ₹330 Cr |
Mar2022 | ₹774 Cr |
Mar2021 | ₹447 Cr |
Mar2020 | ₹622 Cr |
How is Total Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹309 Cr | -6.34 | |
Mar2023 | ₹330 Cr | -57.39 | |
Mar2022 | ₹774 Cr | 73.01 | |
Mar2021 | ₹447 Cr | -28.11 | |
Mar2020 | ₹622 Cr | - |
Compare Total Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,525.3 Cr | -3.1% | 0.2% | 188.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | -3.1% |
0.2% |
188.3% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses